“We want to be competitively unpredictable”
– Psion CEO John Conoley to Stefan Lindegaard.
“The substrate for being able to invent has improved”
– Patrick Vallance, VP Pharmaceuticals Research, GlaxoSmithKline.
“If you want to herd cats, use cat food”
– Dr Chris Watkins, Head of Translational Research, Medical Research Council.
These are just some of the quotes that struck a chord with me today at Open Innovation in Action, the major conference I organised for the bioscience sector on behalf of key client Stevenage Bioscience Catalyst (SBC).
SBC is the UK’s first biomedical open innovation campus – a place where the door that normally exists between small biotechs and big pharma is now literally and metaphorically open.
After the intense buzz that carried on all day I’m suffering right now from too much brain food – I need to process it before writing more.
But for now, it’s clear that the whole event demonstrated there’s some real momentum behind open innovation in bioscience. We’ll be seeing much more in this sector generally and from SBC in particular.
(And if you haven’t guessed – the ‘cats’ comment is about managing clever people with a single-minded determination to work on whatever interests them. )
You might like to share this post: